Home » Topics » Regulatory

Regulatory
RSS

OraPharma's NDA for MPTS accepted for FDA review

April 27, 2000

Lantus approved by FDA for type I and II diabetes

April 27, 2000

New hope for patients suffering from Sjogren's syndrome: FDA approves cevimeline

April 26, 2000

FDA approves Camptosar as first-line treatment of metastatic colorectal cancer

April 25, 2000

Potential new treatment for traumatic brain injury under study at Boehringer Ingelheim

April 25, 2000

Inhalable MS drug enters phase I trials

April 24, 2000

DepoMed reports phase I results for Metformin GR

April 24, 2000

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

April 24, 2000

CV Therapeutics develops sustained-release formulations of ranolazine

April 24, 2000

Humalog now available in Europe to treat children with diabetes

April 24, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...